Clinical Evidence Supports Moving CAR-T Therapies Toward Earlier Treatment in Multiple Myeloma
New clinical evidence highlights the potential of CAR-T cell therapies to transform multiple myeloma treatment across disease stages, moving from last-line treatment toward earlier intervention....
